Orion Oyj (ORINF) Projected to Announce Quarterly Earnings on Wednesday

Orion Oyj (OTCMKTS:ORINF) is anticipated to announce its results before the market opens on Wednesday, October 28th. Analysts expect Orion Oyj to announce earnings of $1.31 per share and revenue of $619.36 million for the quarter.

Orion Oyj Price Performance

Shares of ORINF opened at $92.05 on Tuesday. The company has a 50 day moving average price of $88.89 and a 200-day moving average price of $83.44. Orion Oyj has a fifty-two week low of $78.95 and a fifty-two week high of $92.05.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Danske downgraded shares of Orion Oyj to a “hold” rating in a research note on Friday, October 9th. Jefferies Financial Group upgraded Orion Oyj to a “buy” rating in a report on Sunday. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Orion Oyj currently has a consensus rating of “Moderate Buy”.

Orion Oyj Company Profile

Orion Oyj is a Finnish pharmaceutical company headquartered in Espoo, Finland. Founded in 1917, the company develops, manufactures and markets human and veterinary medicines, as well as active pharmaceutical ingredients and related products.

Orion’s portfolio includes prescription medicines, generic drugs and consumer healthcare products. Its research and commercial activities focus on areas such as oncology, respiratory diseases, neurology, pain management and veterinary medicine. The company also develops proprietary treatments and works with international pharmaceutical partners to advance and commercialize medicines.

Orion serves customers in Finland and international markets, with its products marketed across Europe and in other regions worldwide.